Nalaganje...
Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature
Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...
Shranjeno v:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Limited
2014-01-01
|
| Serija: | BioMed Research International |
| Online dostop: | http://dx.doi.org/10.1155/2014/827327 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|